BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34983494)

  • 1. Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.
    Khamseh ME; Sheikhi A; Shahsavari Z; Ghorbani M; Akbari H; Imani M; Panahi M; Alimohammadi A; Ameri M; Nazem S; Salimi V; Tavakoli-Yaraki M
    BMC Endocr Disord; 2022 Jan; 22(1):1. PubMed ID: 34983494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas.
    Akbari N; Ghorbani M; Salimi V; Alimohammadi A; Khamseh ME; Akbari H; Nourbakhsh M; Sheikhi A; Taghavi SF; Tavakoli-Yaraki M
    BMC Endocr Disord; 2020 Mar; 20(1):39. PubMed ID: 32171274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
    Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
    BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
    Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
    Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas.
    Barooni AB; Ghorbani M; Salimi V; Alimohammadi A; Khamseh ME; Akbari H; Imani M; Nourbakhsh M; Sheikhi A; Shirian FI; Ameri M; Tavakoli-Yaraki M
    Lipids Health Dis; 2019 Jul; 18(1):152. PubMed ID: 31288808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
    Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
    Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of receptor interacting protein 3 and mixed lineage kinase domain-like protein-key proteins in necroptosis is upregulated in ulcerative colitis.
    Wu T; Dai Y; Xue L; Sheng Y; Xu L; Xue Y
    Ann Palliat Med; 2019 Sep; 8(4):483-489. PubMed ID: 31431023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
    Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
    PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway.
    Wang Y; Zhao M; He S; Luo Y; Zhao Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Liu X; Li C; Huang Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):461. PubMed ID: 31706322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
    Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas.
    Grimm F; Maurus R; Beschorner R; Naros G; Stanojevic M; Gugel I; Giese S; Bier G; Bender B; Honegger J
    Acta Neurochir (Wien); 2019 Jun; 161(6):1149-1156. PubMed ID: 31037500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.
    Karami-Tehrani F; Malek AR; Shahsavari Z; Atri M
    Tumour Biol; 2016 Jul; 37(7):8849-56. PubMed ID: 26749282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of necroptosis related genes and lncRNAs in patients with pituitary neuroendocrine tumors.
    Askari A; Darabi MR; Eslami S; Jamali E; Sharifi G; Ghafouri-Fard S; Dilmaghani NA
    Pathol Res Pract; 2024 Jun; 258():155332. PubMed ID: 38696856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
    Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
    Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
    Ando Y; Ohuchida K; Otsubo Y; Kibe S; Takesue S; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Oda Y; Nakamura M
    PLoS One; 2020; 15(1):e0228015. PubMed ID: 31999765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
    Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
    Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.